Results 11 to 20 of about 183,117 (350)

Potential biomarkers for the early detection of bone metastases

open access: yesFrontiers in Oncology, 2023
The clinical manifestations of bone metastases are diversified while many sites remain asymptomatic at early stage. As the early diagnosis method is not perfect and the early symptoms of tumor bone metastasis are not typical, bone metastasis is not easy ...
Yang Hao   +12 more
doaj   +1 more source

A Simple Scoring System Predicting the Survival Time of Patients with Bone Metastases after RT. [PDF]

open access: yesPLoS ONE, 2016
This study aimed to develop a scoring system to predict the survival time of patients with bone metastases after radiation therapy (RT). The scoring system can guide physicians to a better selection of appropriate treatment regimens.The medical records ...
Wen-Yi Zhang   +6 more
doaj   +1 more source

Distribution Features of Skeletal Metastases: A Comparative Study between Pulmonary and Prostate Cancers. [PDF]

open access: yesPLoS ONE, 2015
Bone scintigraphies are widely applied for detecting bone metastases. The aim of this study was to investigate distribution features of bone metastases in pulmonary and prostate cancers.
Changyin Wang, Ying Shen, Shaobo Zhu
doaj   +1 more source

Local surgical complication rates in patients receiving surgery without immediate post-operative radiation therapy for lower extremity bone metastases

open access: yesJournal of Bone Oncology, 2020
Purpose: Pathological metastatic fractures in lower-extremity weight bearing bones often require surgical reconstruction. Post-operative radiation is routinely recommended following surgical reconstruction.
William Pidduck   +5 more
doaj   +1 more source

Incidence of Bone Metastases and Skeletal-Related Events in Patients With EGFR-Mutated NSCLC Treated With Osimertinib

open access: yesJTO Clinical and Research Reports, 2023
Introduction: Bone metastases are frequent in patients with EGFR-mutated (EGFR+) NSCLC. Skeletal-related events (SREs) are common in these patients; however, no data on SRE in osimertinib-treated patients are reported.
Anita J.W. M. Brouns, MD   +8 more
doaj   +1 more source

Pharmacologic management of bone-related complications and bone metastases in postmenopausal women with hormone receptor-positive breast cancer

open access: yesBreast Cancer: Targets and Therapy, 2016
Denise A Yardley1,2 1Sarah Cannon Research Institute, Nashville, TN, USA; 2Tennessee Oncology, Nashville, TN, USA Abstract: There is a high risk for bone loss and skeletal-related events, including bone metastases, in postmenopausal women with hormone ...
Yardley DA
core   +1 more source

A review of spontaneous bone metastases in domestic and laboratory animals. [PDF]

open access: yesJ Bone Oncol
Bone metastases cause significant morbidity and ultimately death in some human cancer patients. Although experimental animal models of skeletal metastases have been invaluable for investigating the molecular mechanisms of cancer progression and growth in
Yuan S   +7 more
europepmc   +2 more sources

Bone metastases of the hand [PDF]

open access: yesThe Annals of The Royal College of Surgeons of England, 2017
Introduction The aim of this study was to identify patients with malignant hand lesions, establish the proportions of those that were metastases and review their clinical course. Methods A retrospective search of a prospective tumour database was carried out to identify all patients treated at our unit with hand metastases.
G, Morris   +6 more
openaire   +2 more sources

Advances in Treatment of Patients with Prostate Cancer Bone Metastases

open access: yesZhongliu Fangzhi Yanjiu, 2020
The incidence of bone metastases is relatively high in prostate cancer (PCa) patients. Bone metastases not only cause pain and increase the risk of skeletal related events (SREs), but also have a significant impact on quality of life and shorten the ...
LI Ning, XIAO Guoyou
doaj   +1 more source

Prevalence and prognosis of bone metastases in common solid cancers at initial diagnosis: a population-based study

open access: yesBMJ Open, 2023
Objective Bone is one of the most common target sites for advanced tumours. The objective was to survey the prevalence and prognosis of bone metastases in 12 common solid malignant tumours.Design A retrospective cohort study.Methods A total of 1 425 332 ...
Jing Zhang, Dongfeng Cai, Song Hong
doaj   +1 more source

Home - About - Disclaimer - Privacy